Connor, Clark & Lunn Investment Management (CC&L)’s Regeneron Pharmaceuticals REGN Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-1,917
| Closed | -$1.22M | – | 1656 |
|
|
2025
Q1 | $1.22M | Buy |
1,917
+983
| +105% | +$623K | 0.01% | 886 |
|
|
2024
Q4 | $665K | Sell |
934
-19,577
| -95% | -$13.9M | ﹤0.01% | 1063 |
|
|
2024
Q3 | $21.6M | Buy |
20,511
+11,008
| +116% | +$11.6M | 0.1% | 159 |
|
|
2024
Q2 | $9.99M | Buy |
9,503
+7,502
| +375% | +$7.88M | 0.04% | 280 |
|
|
2024
Q1 | $1.93M | Sell |
2,001
-185
| -8% | -$178K | 0.01% | 683 |
|
|
2023
Q4 | $1.92M | Sell |
2,186
-480
| -18% | -$422K | 0.01% | 676 |
|
|
2023
Q3 | $2.19M | Sell |
2,666
-14,287
| -84% | -$11.8M | 0.01% | 594 |
|
|
2023
Q2 | $12.2M | Sell |
16,953
-12,834
| -43% | -$9.22M | 0.06% | 228 |
|
|
2023
Q1 | $24.5M | Buy |
29,787
+11,581
| +64% | +$9.52M | 0.13% | 131 |
|
|
2022
Q4 | $13.1M | Buy |
18,206
+13,972
| +330% | +$10.1M | 0.08% | 195 |
|
|
2022
Q3 | $2.92M | Buy |
4,234
+1,106
| +35% | +$762K | 0.02% | 422 |
|
|
2022
Q2 | $1.85M | Sell |
3,128
-5,204
| -62% | -$3.08M | 0.01% | 488 |
|
|
2022
Q1 | $5.82M | Sell |
8,332
-9,407
| -53% | -$6.57M | 0.03% | 303 |
|
|
2021
Q4 | $11.2M | Buy |
17,739
+5,879
| +50% | +$3.71M | 0.05% | 226 |
|
|
2021
Q3 | $7.18M | Sell |
11,860
-13,124
| -53% | -$7.94M | 0.04% | 289 |
|
|
2021
Q2 | $14M | Sell |
24,984
-1,006
| -4% | -$562K | 0.07% | 202 |
|
|
2021
Q1 | $12.3M | Buy |
25,990
+17,687
| +213% | +$8.37M | 0.07% | 199 |
|
|
2020
Q4 | $4.01M | Buy |
8,303
+1,145
| +16% | +$553K | 0.02% | 384 |
|
|
2020
Q3 | $4.01M | Buy |
7,158
+2,310
| +48% | +$1.29M | 0.03% | 349 |
|
|
2020
Q2 | $3.02M | Buy |
4,848
+918
| +23% | +$572K | 0.02% | 386 |
|
|
2020
Q1 | $1.92M | Sell |
3,930
-16,070
| -80% | -$7.85M | 0.02% | 424 |
|
|
2019
Q4 | $7.51M | Buy |
20,000
+14,675
| +276% | +$5.51M | 0.05% | 220 |
|
|
2019
Q3 | $1.48M | Sell |
5,325
-12,225
| -70% | -$3.39M | 0.01% | 476 |
|
|
2019
Q2 | $5.49M | Buy |
17,550
+13,150
| +299% | +$4.12M | 0.04% | 268 |
|
|
2019
Q1 | $1.81M | Buy |
4,400
+1,575
| +56% | +$647K | 0.01% | 427 |
|
|
2018
Q4 | $1.06M | Sell |
2,825
-1,625
| -37% | -$607K | 0.01% | 542 |
|
|
2018
Q3 | $1.8M | Buy |
4,450
+625
| +16% | +$253K | 0.01% | 458 |
|
|
2018
Q2 | $1.32M | Sell |
3,825
-400
| -9% | -$138K | 0.01% | 562 |
|
|
2018
Q1 | $1.46M | Sell |
4,225
-725
| -15% | -$250K | 0.01% | 435 |
|
|
2017
Q4 | $1.86M | Buy |
4,950
+25
| +0.5% | +$9.4K | 0.01% | 427 |
|
|
2017
Q3 | $2.2M | Buy |
4,925
+625
| +15% | +$279K | 0.01% | 403 |
|
|
2017
Q2 | $2.11M | Buy |
4,300
+900
| +26% | +$442K | 0.01% | 382 |
|
|
2017
Q1 | $1.32M | Sell |
3,400
-1,700
| -33% | -$659K | 0.01% | 455 |
|
|
2016
Q4 | $1.87M | Buy |
5,100
+2,100
| +70% | +$771K | 0.01% | 383 |
|
|
2016
Q3 | $1.21M | Sell |
3,000
-2,300
| -43% | -$925K | 0.01% | 445 |
|
|
2016
Q2 | $1.85M | Buy |
5,300
+300
| +6% | +$105K | 0.01% | 376 |
|
|
2016
Q1 | $1.8M | Sell |
5,000
-6,700
| -57% | -$2.41M | 0.01% | 351 |
|
|
2015
Q4 | $6.35M | Sell |
11,700
-8,175
| -41% | -$4.44M | 0.05% | 186 |
|
|
2015
Q3 | $9.25M | Buy |
+19,875
| New | +$9.25M | 0.08% | 131 |
|
|
2014
Q1 | – | Sell |
-10,743
| Closed | -$3.14M | – | 760 |
|
|
2013
Q4 | $3.14M | Buy |
10,743
+4,793
| +81% | +$1.4M | 0.02% | 206 |
|
|
2013
Q3 | $1.91M | Buy |
5,950
+4,750
| +396% | +$1.53M | 0.02% | 201 |
|
|
2013
Q2 | $285K | Buy |
+1,200
| New | +$285K | ﹤0.01% | 433 |
|